Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: Results of a pilot study

PURPOSE: Recurrent high-grade gliomas (HGGs) of childhood have an exceedingly poor prognosis with current therapies. Accordingly, new treatment approaches are needed. We initiated a pilot trial of vaccinations with peptide epitopes derived from glioma-associated antigens (GAAs) overexpressed in thes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurooncol
Autors principals: Pollack, Ian F., Jakacki, Regina I., Butterfield, Lisa H., Hamilton, Ronald L., Panigrahy, Ashok, Normolle, Daniel P., Connelly, Angela K., Dibridge, Sharon, Mason, Gary, Whiteside, Theresa L., Okada, Hideho
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5363717/
https://ncbi.nlm.nih.gov/pubmed/27624914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-016-2245-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars